Improving drug plan efficiencies

The growing impact of high-cost specialty drugs, coupled with shifting roles for health practitioners, calls for stakeholders to work together to improve drug plan efficiencies. But how?

To help answer the question, Benefits Canada organized its 2011 Face-to-Face: Drug Plan Management Forum around the theme of specialty drugs. Held at the Fairmont Royal York Hotel in Toronto on Dec. 1, 2011, the event drew an audience of more than 130 individuals. The following articles highlight the forum’s expert presentations, personal testimonials and panel discussion:

Top three takeaways
  1. Frame the sustainability issue around prioritizing drugs according to their health outcomes rather than avoiding drugs simply because of cost.
  2. Educate plan members about the rationale for therapeutic trade-offs and sharing certain costs with plan sponsors.
  3. Develop a streamlined prior authorization process and explore pooling options to contain the financial risk of underwriting biologic drugs.

Gabrielle Bauer is a freelance writer in Toronto. gbauer@sympatico.ca

Get a PDF of this article.